newsfilter
← Latest News
Business Wire·

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics

Expected to be Effective as of Commencement of Trading on August 15, 2025 ReShape Lifesciences® (NASDAQ:RSLS) announced today that its shareholders have approved all of the proposals necessary to complete the